Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666656 | PMC |
| http://dx.doi.org/10.3389/fendo.2021.794344 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editorial: New insights into prostate cancer: new biomarkers, molecular mechanisms, and therapeutic approaches.
Front Endocrinol (Lausanne)
August 2024
Unidad de Investigación Médica en Medicina Reproductiva, Coordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Commentary: harnessing the first peptidic modulator of the estrogen receptor GPER.
Front Pharmacol
May 2024
Faculty of Pharmacy of Paris, Cibles Thérapeutiques et Conception de Médicaments (CiTCoM), Centre National de la Recherche Scientifique (CNRS) UMR 8038, INSERM U1268, Université Paris Cité, Paris, France.
Editorial: GPER: Control and Functions.
Front Endocrinol (Lausanne)
February 2022
Department of Pharmacology, Tulane University, New Orleans, LA, United States.
Editorial: GPER and Human Pathologies.
Front Endocrinol (Lausanne)
February 2022
Department of Pharmacology, Tulane University, New Orleans, LA, United States.
G protein-coupled estrogen receptor, a potential therapeutic target of asthma probed by Chinese herb.
J Leukoc Biol
July 2020
Center for Traditional Chinese Medicine and Immunology Research, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Discussion on the identification of GPER as a potential therapeutic target for asthma through Chinese herb-driven drug discovery strategy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!